NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,902 | -24.6% | 211,123 | +82.6% | 0.00% | – |
| Q2 2023 | $299,414 | +10968.9% | 115,604 | -82.6% | 0.00% | -100.0% |
| Q1 2023 | $2,705 | +17.6% | 662,966 | +44.7% | 0.00% | +100.0% |
| Q4 2022 | $2,300 | -99.9% | 458,230 | +98.5% | 0.00% | -50.0% |
| Q3 2022 | $3,019,000 | -46.7% | 230,846 | -47.7% | 0.00% | -50.0% |
| Q2 2022 | $5,660,000 | -11.1% | 441,475 | +5.8% | 0.00% | +33.3% |
| Q1 2022 | $6,366,000 | -32.7% | 417,416 | -21.9% | 0.00% | -40.0% |
| Q4 2021 | $9,463,000 | +53.4% | 534,349 | +82.1% | 0.01% | +66.7% |
| Q3 2021 | $6,168,000 | +654.0% | 293,442 | +607.1% | 0.00% | – |
| Q2 2021 | $818,000 | +87.6% | 41,501 | +176.7% | 0.00% | – |
| Q1 2021 | $436,000 | -69.5% | 15,000 | -83.3% | 0.00% | -100.0% |
| Q3 2020 | $1,429,000 | +518.6% | 89,803 | +667.4% | 0.00% | – |
| Q2 2020 | $231,000 | -80.3% | 11,703 | -87.7% | 0.00% | -100.0% |
| Q1 2020 | $1,172,000 | -7.4% | 95,082 | +38.9% | 0.00% | +50.0% |
| Q4 2019 | $1,265,000 | +538.9% | 68,435 | +377.7% | 0.00% | – |
| Q3 2019 | $198,000 | -72.4% | 14,327 | -70.8% | 0.00% | -100.0% |
| Q2 2019 | $718,000 | – | 49,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |